Cell and Gene Therapy, Industry
June 23, 2021
Via: EPM MagazineCancer Research UK will fund, sponsor and conduct the first-in-human Phase 1/2a clinical trial of Aleta’s CAR-T cell engager candidate, ALETA-001. ALETA-001 is part of Aleta’s pipeline of therapies targeting blood cancers and solid tumours. It is being developed to […]
September 19, 2023
September 14, 2023
September 7, 2023
September 5, 2023
September 20, 2023
September 1, 2023
September 14, 2023
August 30, 2023